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Cells tuned for a particular purpose can be grown in bio-films of communicating
elements,going far beyond the conventional idea of DNA computers [31].This is
leading to the emergence of the field of Synthetic Biology, focused on ‘the design
and construction of new biological parts, devices, and systems, and the re-design
of existing, natural biological systems for useful purposes’. MIT is leading the
evolution of this new field through the BioBricks project (http://parts.mit.edu/),
with the development of standard and interchangeable biological parts.
These currently include operators,coding regions,transcriptional terminators and
logic gates.The aim is to provide powerful abstractions so that bio-engineers can
design and build complex biological systems in the same way that electronic
engineers have traditionally built complex electronic circuits, by putting together
high-level logic gates.
Bio-hybrid chips
Customised cells can also be integrated with conventional technology, and
integrated circuits have already been interfaced with microorganisms engineered
for sensing [32].This technology enables the sensing and discrimination of minute
traces of a substance (e.g. a toxin) against a complex chemical background.
Lab-on-chip technology is capable of maintaining the environment required by the
cells resident in such a bio-hybrid chip.The integration of microorganisms into
electronic circuits can be expected to expand significantly within the next 5 years.
Molecular computing
Cell simulation through building such artificial cells is viewed as a widely desirable
goal by systems biologists. However, an alternative engineering approach would
be to design a self-replicating von Neumann machine – natural and artificial cells
can be considered as a special case of a von Neumann Universal Constructor [33].
A chemical synthesis version of the constructor has already been described by
Drexler [34], and ideas for miniaturisation of machines were discussed still earlier
by Penrose and Penrose [35] and Feynman [36].These can all be viewed as special
cases of a Chemical Universal Turing Machine (CUTM) – an abstract computational
device used to investigate what can be computed. It should be possible to build
such an abstract machine with a simple physical realisation.This would be a simple
automaton consisting of a large reaction flask, together with a conveyor belt
containing an arrangement of chemicals. The chemicals would constitute the
‘program’and the automaton would have operations for reading chemicals on the
conveyor, adding and removing them from the reaction flask, and controlling the
temperature of the reaction.The CUTM is a fundamental concept which unifies
lab-on-chip and artificial cell concepts. Clearly, this requires research to establish
its viability but, if successful, could have a dramatic effect on combining
theoretical, experimental and modelling approaches to understanding and
engineering biology.
Much closer to realisation than self-replicating machines are simple molecular
computers. Comparable in capability more to a laundry machine controller than
to a general purpose computer, simple molecular computers are small enough to
operate within a cell.A proof-of-concept of a molecular computer has recently
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been demonstrated, which senses disease-related molecular symptoms, namely
over – and under-expressed genes,analyses the information according to a medical
rule and,if a disease is diagnosed,releases the drug molecule it carries [37];see also
the section ‘Revolutionising Medicine’ in Part 3.This concept is interesting, not
least because it illustrates the potential of combining key concepts from computer
science with chemistry and biology into a new form of therapy: smart drugs for
nano-medicine. In this case, the computer has three modules: an input module
that senses molecular symptoms, a computation module that analyses symptoms
according to pre-programmed medical knowledge, and an output module that
releases the drug. To offset for unreliability of computer components, two types
of automata compute in parallel:one that releases a drug upon positive diagnosis,
and one that releases a drug suppressor upon negative diagnosis.Many hurdles are
to be overcome in developing this into a viable molecular computer for
applications in areas such as smart drugs,yet even if this design does not cross these
hurdles, it might still inspire future designs that would.The consequences would
be dramatic – revolutionising biology and medicine.
Summary
Insights from systems biology combined with an understanding of molecular
mechanisms will increasingly enable the tailoring of cells for specific purposes.
On a long-term perspective, the possibilities created by the emerging tool set of
synthetic biology are enormous. They span from new experimental tools and
techniques to the design and synthesis of entirely new forms of drugs [38].
A detailed understanding of the information processing principles operating within
cells will be crucial to realising these possibilities.
With the simplification of cells to their minimal set of essential genes [39], the
bottom-up implementation of micro-compartmentalised biochemistry [29] and
the integration of cells into circuits [32] well under way, we can expect the
distinction between biological and technical systems to blur in the coming decade.
The computer will be central in this merger of ‘the artificial’ and ‘the living’.
Principles from computer science are already proving essential for addressing the
immense complexity of such an endeavour.
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The distinction between the ‘artificial’and the ‘living’is being increasingly blurred
by new technological advances at the intersection of computing, biology,
chemistry and engineering.These advances have the potential to revolutionise not
only our ability to model, understand and repair complex living systems, but also
to construct new biological parts that may one day be the building blocks of
entirely new organisms.This is a world made possible by labs-on-chips, synthetic
biology and molecular computers.The implications are truly profound, not only
for biology and medicine,but also for human ethics and for protecting our society
against future onslaughts of natural (and engineered) diseases.
Labs on Chips
Living cells are the most sophisticated nano-systems known. The speed with
which they reproduce belies their intricate intracellular organisation.
This organisation gives rise to a very special environment, whose physics is 
characterised by small length scales, surfaces dominating volume, laminar flows,
fast diffusion, and the heat bath, and whose chemistry is dominated by stochastic
fluctuations and highly controlled reactions.Recent progress in microfluidics and
nanotechnology has now opened this unfamiliar environment to practical
engineering experience [29]. Microfluidics has been used to construct systems of
channels and vessels equipped with electrodes and optics for detecting,measuring,
and manipulating solutions, particles, macromolecules or cells. Simple laboratory
work flows, such as sequences of reactions followed by product analysis, can be
implemented on a single chip for mass production.Such micro-reaction chemistry
within confined volumes offers unprecedented control over reaction conditions.
In addition, specific macromolecules or cells can be individually identified and
separated using on-chip methods, enabling new types of experiments to be
conducted. Since the reactions are in small volumes, they consume very little
chemical supplies, enabling extensive studies. Furthermore, high integration on a
single chip enables new types of instrumentation that use embedded chemistry to
perform analysis at the point of measurement.
Synthetic Biology
Although lab-on-chip technology allows for refined control of molecular 
interactions, it pales in comparison to the powerful infrastructure and mass
production capabilities of a living cell. For over two decades, efforts have been
under way to modify cells for factory production of chemicals that are either too
complex for classical synthesis, or that can be produced much more efficiently by
microorganisms (white biotechnology). So far, most of these examples have been
relatively simple and could probably have been identified by classical mutagenesis.
However, as genome-wide computational models become more complex, these
models will enable the construction of cell factories that could change the very
nature of production in the chemical and pharmaceutical industries. The self-
replication capability inherent to cells lends itself to convenient mass production.
More recently,there has also been a shift from static metabolic engineering towards
interfacing with the control structures of cells [30].The possibility to engineer the
dynamics of cellular behaviour opens a path to novel, living biomaterials.
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38Cells tuned for a particular purpose can be grown in bio-films of communicating
elements,going far beyond the conventional idea of DNA computers [31].This is
leading to the emergence of the field of Synthetic Biology, focused on ‘the design
and construction of new biological parts, devices, and systems, and the re-design
of existing, natural biological systems for useful purposes’. MIT is leading the
evolution of this new field through the BioBricks project (http://parts.mit.edu/),
with the development of standard and interchangeable biological parts.
These currently include operators,coding regions,transcriptional terminators and
logic gates.The aim is to provide powerful abstractions so that bio-engineers can
design and build complex biological systems in the same way that electronic
engineers have traditionally built complex electronic circuits, by putting together
high-level logic gates.
Bio-hybrid chips
Customised cells can also be integrated with conventional technology, and
integrated circuits have already been interfaced with microorganisms engineered
for sensing [32].This technology enables the sensing and discrimination of minute
traces of a substance (e.g. a toxin) against a complex chemical background.
Lab-on-chip technology is capable of maintaining the environment required by the
cells resident in such a bio-hybrid chip.The integration of microorganisms into
electronic circuits can be expected to expand significantly within the next 5 years.
Molecular computing
Cell simulation through building such artificial cells is viewed as a widely desirable
goal by systems biologists. However, an alternative engineering approach would
be to design a self-replicating von Neumann machine – natural and artificial cells
can be considered as a special case of a von Neumann Universal Constructor [33].
A chemical synthesis version of the constructor has already been described by
Drexler [34], and ideas for miniaturisation of machines were discussed still earlier
by Penrose and Penrose [35] and Feynman [36].These can all be viewed as special
cases of a Chemical Universal Turing Machine (CUTM) – an abstract computational
device used to investigate what can be computed. It should be possible to build
such an abstract machine with a simple physical realisation.This would be a simple
automaton consisting of a large reaction flask, together with a conveyor belt
containing an arrangement of chemicals. The chemicals would constitute the
‘program’and the automaton would have operations for reading chemicals on the
conveyor, adding and removing them from the reaction flask, and controlling the
temperature of the reaction.The CUTM is a fundamental concept which unifies
lab-on-chip and artificial cell concepts. Clearly, this requires research to establish
its viability but, if successful, could have a dramatic effect on combining
theoretical, experimental and modelling approaches to understanding and
engineering biology.
Much closer to realisation than self-replicating machines are simple molecular
computers. Comparable in capability more to a laundry machine controller than
to a general purpose computer, simple molecular computers are small enough to
operate within a cell.A proof-of-concept of a molecular computer has recently
39
Towards 2020 Science
been demonstrated, which senses disease-related molecular symptoms, namely
over – and under-expressed genes,analyses the information according to a medical
rule and,if a disease is diagnosed,releases the drug molecule it carries [37];see also
the section ‘Revolutionising Medicine’ in Part 3.This concept is interesting, not
least because it illustrates the potential of combining key concepts from computer
science with chemistry and biology into a new form of therapy: smart drugs for
nano-medicine. In this case, the computer has three modules: an input module
that senses molecular symptoms, a computation module that analyses symptoms
according to pre-programmed medical knowledge, and an output module that
releases the drug. To offset for unreliability of computer components, two types
of automata compute in parallel:one that releases a drug upon positive diagnosis,
and one that releases a drug suppressor upon negative diagnosis.Many hurdles are
to be overcome in developing this into a viable molecular computer for
applications in areas such as smart drugs,yet even if this design does not cross these
hurdles, it might still inspire future designs that would.The consequences would
be dramatic – revolutionising biology and medicine.
Summary
Insights from systems biology combined with an understanding of molecular
mechanisms will increasingly enable the tailoring of cells for specific purposes.
On a long-term perspective, the possibilities created by the emerging tool set of
synthetic biology are enormous. They span from new experimental tools and
techniques to the design and synthesis of entirely new forms of drugs [38].
A detailed understanding of the information processing principles operating within
cells will be crucial to realising these possibilities.
With the simplification of cells to their minimal set of essential genes [39], the
bottom-up implementation of micro-compartmentalised biochemistry [29] and
the integration of cells into circuits [32] well under way, we can expect the
distinction between biological and technical systems to blur in the coming decade.
The computer will be central in this merger of ‘the artificial’ and ‘the living’.
Principles from computer science are already proving essential for addressing the
immense complexity of such an endeavour.
Klaus-Peter Zauner, Søren Brunak,Andrew Phillips,
Ehud Shapiro, Stephen Muggleton
Molecular Machines
The distinction between the ‘artificial’and the ‘living’is being increasingly blurred
by new technological advances at the intersection of computing, biology,
chemistry and engineering.These advances have the potential to revolutionise not
only our ability to model, understand and repair complex living systems, but also
to construct new biological parts that may one day be the building blocks of
entirely new organisms.This is a world made possible by labs-on-chips, synthetic
biology and molecular computers.The implications are truly profound, not only
for biology and medicine,but also for human ethics and for protecting our society
against future onslaughts of natural (and engineered) diseases.
Labs on Chips
Living cells are the most sophisticated nano-systems known. The speed with
which they reproduce belies their intricate intracellular organisation.
This organisation gives rise to a very special environment, whose physics is 
characterised by small length scales, surfaces dominating volume, laminar flows,
fast diffusion, and the heat bath, and whose chemistry is dominated by stochastic
fluctuations and highly controlled reactions.Recent progress in microfluidics and
nanotechnology has now opened this unfamiliar environment to practical
engineering experience [29]. Microfluidics has been used to construct systems of
channels and vessels equipped with electrodes and optics for detecting,measuring,
and manipulating solutions, particles, macromolecules or cells. Simple laboratory
work flows, such as sequences of reactions followed by product analysis, can be
implemented on a single chip for mass production.Such micro-reaction chemistry
within confined volumes offers unprecedented control over reaction conditions.
In addition, specific macromolecules or cells can be individually identified and
separated using on-chip methods, enabling new types of experiments to be
conducted. Since the reactions are in small volumes, they consume very little
chemical supplies, enabling extensive studies. Furthermore, high integration on a
single chip enables new types of instrumentation that use embedded chemistry to
perform analysis at the point of measurement.
Synthetic Biology
Although lab-on-chip technology allows for refined control of molecular 
interactions, it pales in comparison to the powerful infrastructure and mass
production capabilities of a living cell. For over two decades, efforts have been
under way to modify cells for factory production of chemicals that are either too
complex for classical synthesis, or that can be produced much more efficiently by
microorganisms (white biotechnology). So far, most of these examples have been
relatively simple and could probably have been identified by classical mutagenesis.
However, as genome-wide computational models become more complex, these
models will enable the construction of cell factories that could change the very
nature of production in the chemical and pharmaceutical industries. The self-
replication capability inherent to cells lends itself to convenient mass production.
More recently,there has also been a shift from static metabolic engineering towards
interfacing with the control structures of cells [30].The possibility to engineer the
dynamics of cellular behaviour opens a path to novel, living biomaterials.
Building Blocks of a Scientific Revolution
38